24. – 26. 1.
2018
PRAHA

ZÁZNAMY Z PŘEDNÁŠEK

STATE OF THE ART: OPTIMAL SCHEDULE OF ANTI-HER2 TREATMENT AND METASTATIC BREAST CANCER

PROF. JOSEPH GLIGOROV, MD, PHD

TREATMENT OF METASTATIC CRPC 2016 – THE ONCOLOGISTS PERSPECTIVE

JOE O’SULLIVAN

CHIMERIC ANTIGEN RECEPTORS (CAR) T-CELL THERAPY AS NEW TARGETED THERAPY FOR SOLID CANCER

PROF. JOANNA CHOROSTOWSKA-WYNIMKO, MD, PHD, DSC

DISCOVERY AND DEVELOPMENT OF A NEW CYTOTOXIC AGENT FOR TREATMENT OF ADVANCED BREAST

BRUCE A. LITTLEFIELD, PHD

STATE OF THE ART HORMONAL TREATMENT IN METASTATIC BREAST CANCER

MARTINE PICCART, MD, PHD

ADVANCED NSCLC STATE-OF-THE-ART TREATMENT

UNIV. PROF. MAG. DR. ROBERT PIRKER

UPDATES ON CRC FROM ASCO GI 2016

AXEL GROTHEY, M.D.

STATE OF THE ART: METASTATIC COLORECTAL CANCER

AXEL GROTHEY, M.D.